Table of Contents

Selective serotonin reuptake inhibitors (SSRIs) represent one of the most widely prescribed classes of medications for treating depression, anxiety disorders, and various other mental health conditions. While these medications have helped millions of people manage their symptoms and improve their quality of life, the long-term use of SSRIs presents a complex landscape of benefits, risks, and important considerations that both patients and healthcare providers must carefully navigate.

Understanding SSRIs and How They Work

SSRIs function by increasing the availability of serotonin in the brain, a neurotransmitter that plays a crucial role in regulating mood, emotions, and various cognitive functions. By blocking the reuptake of serotonin at the synaptic level, these medications allow more of this chemical messenger to remain active in the brain, which can help alleviate symptoms of depression and anxiety.

These medications are typically prescribed as the first-line treatment for a range of mental health conditions, including major depressive disorder, generalized anxiety disorder, panic disorder, obsessive-compulsive disorder, post-traumatic stress disorder, and social anxiety disorder. Common SSRIs include fluoxetine (Prozac), sertraline (Zoloft), paroxetine (Paxil), citalopram (Celexa), and escitalopram (Lexapro).

SSRIs were better tolerated compared with older tricyclic antidepressants and a week's supply was not lethal in overdose. This improved safety profile has contributed to their widespread adoption in clinical practice over the past several decades.

The Growing Trend of Long-Term SSRI Use

The duration of SSRI use in real-world practice has increased significantly over recent years. According to the National Health and Nutrition Examination Survey (NHANES) of 2005-2008 and 2011-2014, the proportion of individuals taking antidepressants for 10 years or more in the United States increased from 13.6%-25.3%. This trend reflects a shift in prescribing patterns, with many patients remaining on these medications for extended periods.

The median duration of antidepressant use in the United States is approximately 5 years, yet 88.5% of clinical trials supporting these medications last 12 weeks or less. A 2025 analysis of 52 placebo-controlled trials examining the most commonly prescribed antidepressants found that the median trial duration was just 8 weeks. The median duration of use in the United States reaches 260 weeks—over 30 times longer than the typical trial duration.

This significant gap between research evidence and real-world practice raises important questions about what we truly understand regarding the long-term effects of these medications.

Benefits of Long-Term SSRI Use

For many individuals living with chronic or recurrent mental health conditions, long-term SSRI therapy can provide substantial benefits that significantly improve their quality of life and daily functioning.

Sustained Symptom Management

One of the primary advantages of continued SSRI use is the maintenance of stable mood and reduced anxiety levels. For individuals with chronic depression or anxiety disorders, ongoing medication can help prevent the return of debilitating symptoms that interfere with work, relationships, and overall well-being. Many patients report that consistent medication use allows them to maintain emotional stability and engage more fully in their daily activities.

Reduced Risk of Relapse

Long-term treatment with SSRIs can significantly lower the chances of symptom recurrence in individuals with a history of depression or anxiety. For those who have experienced multiple episodes of major depression, continuing medication beyond the acute treatment phase may help prevent future relapses and maintain the gains achieved during initial treatment.

Improved Overall Functioning

Patients who maintain stable treatment often experience better overall functioning across multiple life domains. This can include improved performance at work or school, enhanced relationships with family and friends, increased ability to engage in social activities, and greater capacity to pursue personal goals and interests. The stability provided by effective long-term treatment can create a foundation for other positive life changes.

Accessibility and Tolerability

SSRIs are widely available, relatively affordable compared to some other treatment options, and generally well-tolerated by many patients. This makes them a practical choice for long-term management of chronic mental health conditions. For many, SSRIs have been profoundly helpful in managing their health and continue to have an important place in care.

Risks and Side Effects Associated with Long-Term SSRI Use

While SSRIs can be beneficial, extended use is associated with various potential risks and side effects that patients and healthcare providers should carefully consider and monitor.

Common Persistent Side Effects

The most frequently reported side effects for selective serotonin reuptake inhibitors (SSRIs) were dry mouth, profuse sweating, sexual dysfunction, and weight gain. These side effects can persist throughout the duration of treatment and may become increasingly bothersome over time.

Sexual Dysfunction

Sexual side effects represent one of the most commonly reported and distressing long-term effects of SSRI use. These can include decreased libido, difficulty achieving arousal, delayed orgasm, or inability to reach orgasm. For some individuals, these effects can significantly impact intimate relationships and overall quality of life. In rare cases, a condition known as post-SSRI sexual dysfunction may persist even after discontinuing the medication, though most people experience improvement over time after stopping treatment.

Weight Changes

Weight gain is another frequently reported side effect of long-term SSRI use. Weight gain can occur gradually over months or years. This can affect physical health and self-esteem. The mechanisms behind SSRI-related weight gain are not fully understood but may involve changes in metabolism, increased appetite, or alterations in how the body processes and stores energy.

Sleep Disturbances

Sleep disturbance (multiple long-wake periods) are adverse effects of long-term SSRI use. Some SSRIs can cause insomnia or disrupted sleep patterns, while others may cause excessive drowsiness. The specific effects can vary depending on the individual medication and the person taking it.

Emotional Blunting

A significant concern for many long-term SSRI users is the experience of emotional blunting or emotional numbing. Other adverse effects written about by participants included increases in numbing or emotional bluntness. They numb all your feelings, both positive and negative. This phenomenon involves a reduction in the intensity of both positive and negative emotions, leaving some individuals feeling disconnected from their feelings or less able to experience joy, excitement, or even appropriate sadness.

While some degree of emotional dampening may be helpful during severe depression, for others it becomes distressing and can impact their sense of self and their relationships with others.

Physical Health Concerns

There is also increased risks of osteoporosis and fracture, bleeding disorders, hyponatremia, and diabetes mellitus. These physical health risks require ongoing monitoring, particularly in older adults or those with pre-existing health conditions.

There was some evidence of a dose–response effect for all-cause mortality, with higher doses associated with an increased risk of this outcome. However, it's important to note that these associations are complex and may be influenced by the underlying conditions being treated rather than the medications themselves.

Cardiovascular Considerations

Research has shown mixed findings regarding cardiovascular effects. Any antidepressant use was associated with a reduction in incident hypertension (fully adjusted hazard ratio 0.80, 95% CI 0.70–0.91), as was SSRI use (hazard ratio 0.77, 95% CI 0.66–0.89). However, other studies have found associations between SSRI use and increased risk of certain cardiovascular events, highlighting the need for individualized risk assessment.

Suicidal Ideation

In 2004, the FDA issued a black box warning about a possible increased risk of suicidality in young adults taking an SSRI. This risk appears to be highest during the initial weeks of treatment or when doses are changed, and requires careful monitoring, particularly in younger patients.

Emerging Research on Genotoxicity

Long-term SSRI use has prompted concern about genotoxicity, particularly for citalopram, which shows the most consistent in vivo DNA-damage signals. While this research is still emerging and its clinical significance remains unclear, it represents an area requiring further investigation.

The Challenge of Discontinuation: Understanding Withdrawal Symptoms

One of the most significant challenges associated with long-term SSRI use is the difficulty many people experience when attempting to stop taking these medications. It is now widely accepted that SSRIs can cause a protracted withdrawal syndrome, necessitating a gradual tapering when they are stopped.

What is Antidepressant Discontinuation Syndrome?

Antidepressant discontinuation syndrome (ADS) can happen if you stop taking your antidepressant. It causes symptoms like nausea and dizziness, as well as flu-like symptoms. This syndrome occurs when the brain, which has adapted to the presence of the medication, must readjust to functioning without it.

Studies show that 27% to 86% of people who attempt to stop antidepressants, whether on their own or under the supervision of a healthcare provider, experience ADS. The wide range in these estimates reflects differences in study methodologies, populations studied, and definitions of withdrawal symptoms.

Common Withdrawal Symptoms

Fifty-three different symptoms were reported, with dizziness being the most common. Other common symptoms were nausea or emesis, fatigue, headache, gait instability and insomnia. Additional symptoms can include anxiety, irritability, vivid dreams, electric shock-like sensations (often called "brain zaps"), flu-like symptoms, and mood changes.

Symptoms of antidepressant discontinuation syndrome typically begin within two to four days of stopping an antidepressant. Symptoms include: Flu-like symptoms, including fatigue, headache, achiness and sweating.

Duration and Severity of Withdrawal

Most cases of discontinuation syndrome may last between one and four weeks and resolve on their own. Occasionally symptoms can last up to one year. However, for some individuals, particularly those who have been on SSRIs for extended periods, withdrawal symptoms can be more prolonged.

Among long-term users, 30% reported withdrawal symptoms persisting for more than 3 months, with 12% experiencing such symptoms for more than a year, while only 10.5% of short-term users experienced withdrawal symptoms for more than 3 months. This suggests that the duration of SSRI use may influence the severity and duration of withdrawal symptoms.

Paroxetine and venlafaxine seem to be particularly difficult to discontinue, and prolonged withdrawal syndrome (post-acute-withdrawal syndrome, or PAWS) lasting over 18 months has been reported with paroxetine.

Factors Affecting Withdrawal Risk

The antidepressants most likely to cause troublesome symptoms are those that have a short half-life — that is, they break down and leave the body quickly. Examples include venlafaxine (Effexor), sertraline (Zoloft), paroxetine (Paxil), and citalopram (Celexa). Medications with longer half-lives, such as fluoxetine (Prozac), tend to cause fewer and less severe withdrawal symptoms.

Distinguishing Withdrawal from Relapse

One of the challenges in managing SSRI discontinuation is distinguishing between withdrawal symptoms and a return of the underlying condition. Whenever I have tried to stop, I find I "relapse" or experience withdrawal symptoms. This difficulty in differentiating between the two can lead to uncertainty about whether to resume medication or continue with the discontinuation process.

Important Considerations for Long-Term SSRI Use

Given the complex balance of benefits and risks, several key factors should guide decisions about long-term SSRI therapy.

Regular Monitoring and Evaluation

Ongoing assessment of mental health status and medication effectiveness is crucial for anyone taking SSRIs long-term. This should include regular check-ins with healthcare providers to evaluate symptom control, side effects, quality of life, and overall functioning. Monitoring should also include periodic assessment of physical health markers, particularly those that may be affected by long-term SSRI use.

Individualized Treatment Plans

Treatment should be tailored to each individual's specific needs, circumstances, and responses to medication. What works well for one person may not be appropriate for another. Factors to consider include the severity and chronicity of symptoms, history of relapse, response to previous treatments, side effect profile, other medical conditions, and personal preferences and goals.

The Evidence Gap

This gap, compounded by inadequate monitoring for withdrawal effects and post-treatment outcomes, raises important questions about the evidence supporting current long-term prescribing practices. Publicly funded trials of longer duration that include monitoring for withdrawal and relapse are necessary to determine optimal antidepressant therapy duration.

The limited long-term research means that many decisions about extended SSRI use must be made based on clinical judgment, individual response, and careful risk-benefit analysis rather than robust long-term trial data.

Combination Approaches

Combining SSRIs with psychotherapy or lifestyle modifications may enhance treatment outcomes and potentially allow for lower medication doses or shorter treatment duration. Cognitive-behavioral therapy (CBT), interpersonal therapy, mindfulness-based interventions, regular exercise, sleep hygiene practices, stress management techniques, and nutritional approaches can all complement medication treatment.

Research suggests that combining medication with psychotherapy may be more effective than either approach alone for many individuals, and may also reduce the risk of relapse when medication is eventually discontinued.

Informed Decision-Making

Patients should receive comprehensive education about both the benefits and risks of SSRIs to make informed choices regarding their treatment. This includes understanding potential side effects, the possibility of withdrawal symptoms, the expected timeline for symptom improvement, alternatives to medication, and the importance of not stopping medication abruptly without medical guidance.

Patients should not stop taking SSRIs nor physicians cease prescribing them. However, decisions about continuing or discontinuing treatment should be made collaboratively between patients and their healthcare providers, with full consideration of individual circumstances.

Safely Discontinuing SSRIs: Best Practices

For individuals who decide to stop taking SSRIs, whether due to side effects, achievement of treatment goals, or personal preference, a careful and gradual approach is essential.

The Importance of Gradual Tapering

For SSRIs, a tapered discontinuation results in less severe symptoms. Rather than stopping abruptly, doses should be reduced gradually over weeks or months, depending on the specific medication, dose, and duration of use.

Many of the symptoms of SSRI discontinuation syndrome can be minimized or prevented by gradually lowering, or tapering, the dose over weeks to months, sometimes substituting longer-acting drugs such as fluoxetine (Prozac) for shorter-acting medications.

Working with Healthcare Providers

Discontinuation should always be undertaken under medical supervision. Healthcare providers can develop an individualized tapering schedule, monitor for withdrawal symptoms and relapse, provide support and guidance throughout the process, and adjust the plan as needed based on the individual's response.

It's important to talk to your healthcare provider if you're considering stopping an antidepressant to try to prevent ADS. Because of this, it's crucial to go off an antidepressant under the guidance of your healthcare provider.

Monitoring During Discontinuation

Close monitoring during the discontinuation process is essential to distinguish between withdrawal symptoms and relapse of the underlying condition. This may involve more frequent appointments, symptom tracking, and maintaining open communication with healthcare providers about any changes in mood, anxiety, or physical symptoms.

When to Seek Immediate Help

While most discontinuation symptoms are uncomfortable but not dangerous, certain symptoms require immediate medical attention. These include thoughts of self-harm or suicide, severe anxiety or panic attacks, significant worsening of depression, psychotic symptoms, or any other symptoms that feel overwhelming or unmanageable.

Special Populations and Considerations

Older Adults

Older adults may be at increased risk for certain side effects of long-term SSRI use, including falls and fractures related to bone density changes, hyponatremia (low sodium levels), and interactions with other medications. However, they may also benefit significantly from treatment of depression and anxiety, which can improve overall health outcomes and quality of life.

Young Adults and Adolescents

The use of SSRIs in younger populations requires particularly careful monitoring due to the increased risk of suicidal ideation, especially during the initial weeks of treatment. The decision to use SSRIs in this age group should involve careful consideration of risks and benefits, close monitoring, and often combination with psychotherapy.

Pregnancy and Breastfeeding

Women who are pregnant or planning to become pregnant face complex decisions about SSRI use. While untreated depression and anxiety can pose risks to both mother and baby, SSRIs can cross the placenta and may affect fetal development. These decisions require careful discussion with healthcare providers to weigh the risks and benefits in each individual situation.

The Broader Context: Effectiveness and Controversy

The effectiveness of SSRIs has been the subject of ongoing debate in the medical and scientific communities. A 2018 meta-analysis in The Lancet concluded that all antidepressants are more efficacious than placebo in adults with a diagnosis of major depressive disorder, with odds ratios ranging between 2·23 and 1·37. However, questions remain about the clinical significance of these effects and how they translate to real-world outcomes.

Even though the median publication year was 2013, and even though all the trials we reviewed had a follow-up of at least 24 weeks after the randomised phase, none of them reported adequately on persisting harms of SSRIs; in fact, the reporting was very poor and selective. The authors were not even interested in reporting withdrawal effects although they likely occurred in all the trials.

This lack of comprehensive reporting on long-term outcomes and harms in clinical trials highlights the need for more transparent and complete research on the long-term effects of SSRI use.

Alternative and Complementary Approaches

For individuals concerned about long-term SSRI use or those seeking to reduce their reliance on medication, several alternative and complementary approaches may be beneficial.

Psychotherapy

Various forms of psychotherapy, including cognitive-behavioral therapy (CBT), interpersonal therapy, psychodynamic therapy, and acceptance and commitment therapy (ACT), have demonstrated effectiveness for depression and anxiety disorders. For some individuals, psychotherapy alone may be sufficient, while others may benefit from combining therapy with medication.

Lifestyle Interventions

Regular physical exercise, adequate sleep, stress management techniques, healthy nutrition, social connection and support, and mindfulness and meditation practices can all contribute to improved mental health and may reduce the need for medication or support medication effectiveness.

Other Treatment Options

Depending on the specific condition and individual circumstances, other treatment options may include different classes of medications, brain stimulation therapies such as transcranial magnetic stimulation (TMS), light therapy for seasonal affective disorder, or complementary approaches such as acupuncture or omega-3 supplementation.

Looking Forward: The Need for Better Research

50 years on from landmark developments in drug treatment that were the cause of so much hope, we remain a long way from providing the level of care that so many people need, and this need continues to demand the attention of the scientific and medical communities.

The field of mental health treatment would benefit greatly from longer-duration clinical trials that more accurately reflect real-world prescribing patterns, better reporting of adverse effects and withdrawal symptoms, research on optimal treatment duration for different populations and conditions, studies comparing medication to psychotherapy and combined approaches over the long term, and investigation of factors that predict who will benefit most from long-term SSRI use.

Practical Guidance for Patients

If you are currently taking or considering long-term SSRI therapy, here are some practical steps to optimize your treatment:

  • Maintain regular communication with your healthcare provider about your symptoms, side effects, and overall well-being
  • Keep track of your mood, anxiety levels, and any side effects you experience
  • Don't make changes to your medication regimen without consulting your healthcare provider
  • Be honest about any concerns or difficulties you're experiencing with your medication
  • Ask questions about your treatment plan and make sure you understand the rationale for continuing or changing your medication
  • Consider complementary approaches such as therapy, exercise, and stress management
  • Educate yourself about your condition and treatment options from reliable sources
  • Build a support network of family, friends, or support groups
  • If you're considering discontinuing your medication, work with your healthcare provider to develop a safe tapering plan
  • Be patient with yourself and recognize that finding the right treatment approach may take time

Conclusion: Balancing Benefits and Risks

The long-term use of SSRIs presents a complex picture of significant potential benefits balanced against real risks and challenges. For many individuals suffering from chronic or recurrent depression and anxiety disorders, these medications can be life-changing, providing relief from debilitating symptoms and enabling fuller participation in life's activities and relationships.

However, the decision to continue SSRIs long-term should not be made lightly or automatically. It requires ongoing evaluation of whether the benefits continue to outweigh the risks, careful monitoring for side effects and complications, consideration of alternative or complementary approaches, and planning for eventual discontinuation when appropriate.

The significant gap between the duration of clinical trials and real-world use patterns means that much about long-term SSRI effects remains incompletely understood. This uncertainty underscores the importance of individualized treatment decisions, regular monitoring, and open communication between patients and healthcare providers.

Ultimately, the goal of mental health treatment is not simply to prescribe medication, but to help individuals achieve the best possible quality of life with the least burden from both their condition and their treatment. For some, this will involve long-term SSRI use; for others, shorter-term medication combined with other approaches may be more appropriate.

By staying informed about both the benefits and risks of SSRIs, engaging in ongoing discussions with healthcare providers, and taking an active role in treatment decisions, patients can navigate their mental health care more effectively and work toward optimal outcomes. As research continues to evolve and our understanding of these medications deepens, treatment approaches will continue to be refined to better serve the diverse needs of individuals living with depression and anxiety disorders.

For more information about mental health treatment options, visit the National Institute of Mental Health or the National Alliance on Mental Illness. If you're experiencing a mental health crisis, contact the 988 Suicide and Crisis Lifeline by calling or texting 988.